Literature DB >> 1707537

Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.

A Brooks1, S Hartley, L Kjer-Nielsen, J Perera, C C Goodnow, A Basten, J McCluskey.   

Abstract

An in vitro model was used to investigate the potential for different structural forms of endogenous antigen to be processed and presented by major histocompatibility complex class II molecules. For this purpose the class II-restricted presentation of an immunodominant epitope of hen egg lysozyme [HEL-(46-61)] was studied in class II-positive B-lymphoma cells (M12.C3) transfected with genes encoding HEL molecules either (i) secreted in high (hi) or low (lo) amounts as soluble antigen [sHEL(hi/lo)], (ii) localized within the endoplasmic reticulum (ER)/salvage compartment (ER-HEL), or (iii) anchored on the cell surface as an integral membrane protein (mHEL). The corresponding sHEL, ER-HEL, and mHEL gene products were expressed as predicted except that HEL determinants accumulated in the culture supernatant as well as on the cell membrane of mHEL-transfected cells. Class II-positive cells endogenously expressing all three forms of HEL antigen constitutively presented the immunodominant HEL-(46-61) determinant with differential efficiency (mHEL, sHEL greater than ERHEL) to a class II-restricted T hybridoma. A second T hybridoma recognized endogenous HEL-(46-61) determinants constitutively presented on sHEL(hi) and mHEL transfectants but not on sHEL(lo) or ERHEL transfectants. The formation of HEL-(46-61)/I-Ak complexes in the ERHEL and sHEL(lo) transfectants was therefore limiting. Mixing experiments with different antigen-presenting cells indicated that the HEL-(46-61) determinant was derived from endogenous antigen rather than by reuptake of shed or secreted HEL determinants. We conclude that MHC class II molecules can present some antigenic determinants derived from endogenous proteins that are sequestered in the ER/salvage compartment as well as distally transported in the form of secretory or membrane antigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707537      PMCID: PMC51432          DOI: 10.1073/pnas.88.8.3290

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Protein degradation in the endoplasmic reticulum.

Authors:  R D Klausner; R Sitia
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

2.  The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.

Authors:  D B Thomas; J Hodgson; P F Riska; C M Graham
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

Review 3.  The binary logic of antigen processing and presentation to T cells.

Authors:  J W Yewdell; J R Bennink
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

Review 4.  Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment.

Authors:  L E Guagliardi; B Koppelman; J S Blum; M S Marks; P Cresswell; F M Brodsky
Journal:  Nature       Date:  1990-01-11       Impact factor: 49.962

5.  The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.

Authors:  L Kjer-Nielsen; J D Perera; L F Boyd; D H Margulies; J McCluskey
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

6.  Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway.

Authors:  J Lippincott-Schwartz; J G Donaldson; A Schweizer; E G Berger; H P Hauri; L C Yuan; R D Klausner
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

7.  Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.

Authors:  L Adorini; S J Ullrich; E Appella; S Fuchs
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

8.  Class II MHC molecules can use the endogenous pathway of antigen presentation.

Authors:  J G Nuchtern; W E Biddison; R D Klausner
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

9.  Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.

Authors:  B P Chen; A Madrigal; P Parham
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.

Authors:  D Jaraquemada; M Marti; E O Long
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules.

Authors:  C A Nelson; I Vidavsky; N J Viner; M L Gross; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens.

Authors:  Srdjan M Dragovic; Timothy Hill; Gregory J Christianson; Sungjune Kim; Tim Elliott; Diane Scott; Derry C Roopenian; Luc Van Kaer; Sebastian Joyce
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

Review 5.  Endogenous antigen presentation by MHC class II molecules.

Authors:  A J Sant
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.

Authors:  S Tangri; L Brossay; N Burdin; D J Lee; M Corr; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

7.  Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment.

Authors:  S Demotz; W Ammerlaan; P Fournier; C P Muller; C Barbey
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. I. Generation of human thyroid peroxidase-reactive T cells and their T cell receptor repertoire.

Authors:  A Martin; R P Magnusson; D L Kendler; E Concepcion; A Ben-Nun; T F Davies
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 9.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.